IMMUNOHISTOCHEMICAL LOCALIZATION OF THE CA2+ BINDING S100 PROTEINS INNORMAL HUMAN SKIN AND MELANOCYTIC LESIONS

Citation
R. Boni et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF THE CA2+ BINDING S100 PROTEINS INNORMAL HUMAN SKIN AND MELANOCYTIC LESIONS, British journal of dermatology, 137(1), 1997, pp. 39-43
Citations number
19
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
00070963
Volume
137
Issue
1
Year of publication
1997
Pages
39 - 43
Database
ISI
SICI code
0007-0963(1997)137:1<39:ILOTCB>2.0.ZU;2-0
Abstract
The purpose of this study was to evaluate the expression of the Ca2+-b inding S100 proteins S100A1, S100A2, S100A3, S100A4, S100A6 and S100B in normal skin, These immunohistochemical staining patterns were compa red with those in melanocytic lesions. Paraffin-embedded tissue of nor mal skin adjacent to 26 naevi, 39 primary cutaneous melanomas and 14 c utaneous melanoma metastases was incubated with polyclonal antibodies against the recombinant human S100 proteins (S100A1, S100A2, S100A3, S 100A4, S100A6, S100B) using the alkaline phosphatase anti-alkaline pho sphatase method. The S100A2 antibody stained the basal layer of the ep idermis and hair follicles of normal skin. Four of 39 primary cutaneou s melanomas were positive for S100A2, whereas none of the metastases o r naevi showed any immunoreactivity. The S100A3 antibody only stained the inner root sheath cuticle of some hair follicles but no melanocyte s or melanocytic lesions. Staining of S100A4 was weak and thus omitted to further analysis. S100A6 faintly labelled keratinocytes, Langerhan s' cells, melanocytes and sweat glands. S100A6 immunoreaction was foun d in two of seven junctional naevi, five of seven compound naevi, and all dermal and blue naevi. There was an intense cytoplasmatic reaction for S100A6 in all primary cutaneous melanomas and in nine of 14 (64%) metastases. S100B was positive in melanocytes and Langerhans' cells, all primaries as well as in the metastases. S100A1 protein was not det ected on ally of the tissue specimens examined. Whereas S100B and S100 A6 antibodies are useful markers for malignant melanoma, expression of S100A4 antibody is too low to be used for immunohistochemical stainin g. S100A1 and S100A3 antibodies are not expressed in melanocytic lesio ns and S100A2 is only found in selected tumours. The investigated S100 proteins, including S100B and S100A6, are also expressed in selected elements of normal skin, These findings are important for correct inte rpretation of staining patterns, when S100 antibodies are used as mark ers for melanoma or other tumours.